(0.30%) 5 115.49 points
(0.31%) 38 356 points
(0.34%) 15 982 points
(-0.89%) $83.10
(5.77%) $2.03
(0.37%) $2 355.80
(0.46%) $27.66
(4.03%) $959.25
(-0.23%) $0.933
(-0.38%) $10.98
(-0.55%) $0.796
(1.69%) $93.43
Quarter results tomorrow
(bmo 2024-04-30)
Expected move: +/- 9.68%
@ $8.06
発行日: 15 2月 2024 @ 05:17
リターン: -22.21%
前回のシグナル: 2月 15 - 01:43
前回のシグナル:
リターン: 0.62 %
Live Chart Being Loaded With Signals
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins...
Stats | |
---|---|
本日の出来高 | 250 824 |
平均出来高 | 820 616 |
時価総額 | 925.35M |
EPS | $0 ( 2024-02-28 ) |
次の収益日 | ( $0.0700 ) 2024-04-30 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 14.58 |
ATR14 | $0.00700 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Hulse William Frank Iv | Sell | 8 896 | Common Stock |
2024-04-08 | Hulse William Frank Iv | Sell | 8 896 | Common Stock |
2024-03-01 | Puhy Dorothy E | Buy | 0 | |
2024-03-01 | Olson Tiffany | Buy | 0 | |
2024-03-13 | Hulse William Frank Iv | Sell | 20 381 | Common Stock |
INSIDER POWER |
---|
97.67 |
Last 95 transactions |
Buy: 35 462 522 | Sell: 808 933 |
ボリューム 相関
MiMedx Group Inc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
MiMedx Group Inc 相関 - 通貨/商品
MiMedx Group Inc 財務諸表
Annual | 2023 |
収益: | $321.48M |
総利益: | $266.84M (83.01 %) |
EPS: | $0.400 |
FY | 2023 |
収益: | $321.48M |
総利益: | $266.84M (83.01 %) |
EPS: | $0.400 |
FY | 2022 |
収益: | $267.84M |
総利益: | $219.53M (81.96 %) |
EPS: | $-0.270 |
FY | 2021 |
収益: | $258.62M |
総利益: | $215.33M (83.26 %) |
EPS: | $-0.0932 |
Financial Reports:
No articles found.
MiMedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。